# Steroids for Early Treatment of Radiation Retinopathy

> **NCT03238157** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **The Cleveland Clinic**

## Conditions studied

- Radiation Retinopathy

## Interventions

- **DRUG:** Fluocinolone Acetonide (FA) implant

## Key facts

- **NCT ID:** NCT03238157
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2021-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03238157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03238157, "Steroids for Early Treatment of Radiation Retinopathy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03238157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*